previous compound ID: 1697 next compound
InChIKey: PHEDXBVPIONUQT-RGYGYFBISA-N
SMILES: CCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)O)CO)[C@H]4[C@@]1(C4(C)C)OC(=O)C)O)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"D Rotin" "JW Hanrahan" "R Robert" "GW Carlile" "E Matthes" "J Goepp" "B Kus" "DY Thomas" "J Liao" "SD Macknight"

chemical graph of compound 1697





CID is 27924
synonyms found at PubChem are:
Phorbol 12-myristate 13-acetate, 16561-29-8, 12-O-Tetradecanoylphorbol-13-acetate, 12-O-Tetradecanoylphorbol 13-acetate, Factor A1, Tetradecanoylphorbol acetate, 12-Tetradecanoylphorbol 13-acetate, Factor A1 (croton oil), phorbol 13-acetate 12-myristate, phorbol-12-myristate-13-acetate, Phorbol myristate acetate, PMA, Phorbol ester, Phorbol 12-tetradecanoate 13-acetate, UNII-NI40JAQ945, CCRIS 716, HSDB 3542, beta-Phorbol 12-myristate 13-acetate, 4beta-Phorbol 12-myristate 13-acetate, PMA (tumor promoter), CHEMBL279115, NI40JAQ945, TPA (phorbol derivative), CHEBI:37537, tetradecanoyl-beta-phorbol acetate, Phorbol monoacetate monomyristate, 13-O-Acetylphorbol 12-myristate, 12-O-Tetradecanoyl phorbol acetate, NSC 262244, 12-Tetradecanoylphorbol 13-monoacetate, 12-o-Tetradekanoylphorbol-13-acetat, Pentahydroxy-tigliadienone-monoacetate(c)monomyristate(b), 12-o-tetradecanoyl phorbol-13-acetate, yristate, NSC626496, 5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one, 1,1a-beta,1b-alpha,4,4a,7a-beta,7b,8,9,9a-decahydro-4a-alpha,7b-beta,9-alpha,9a-beta-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-beta-tetramethyl-, 9a-acetate 9-myristate, Tetradecanoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9, 9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester, (1aR-(1aa,1bb,4ab,7aa,7ba, 8a,9b,9aa))-, 12-o-tetradecanoyl-phorbol-13-acetate, SpecPlus_000801, Spectrum2_001911, Spectrum4_000889, Spectrum5_001855, D09DHT, MolMap_000041, UPCMLD-DP069, AC1L1E8S, BIDD:PXR0145, CBiol_002014, BSPBio_001024, KBioGR_000364, KBioGR_001298, KBioSS_000364, SPECTRUM330004, DivK1c_006897, SCHEMBL115567, SPBio_001902, 1H-Cyclopropa[3,4]benz[1,2-e]azulene, tetradecanoic acid deriv., GTPL2341, [acetoxy-dihydroxy-(hydroxymethyl)-tetramethyl-oxo-[?]yl] tetradecanoate, DTXSID5023798, UPCMLD-DP069:001, UPCMLD-DP069:002, BCBcMAP01_000182, CTK8G2455, KBio1_001841, KBio2_000364, KBio2_002932, KBio2_005500, KBio3_000707, KBio3_000708, MolPort-003-665-586, PHEDXBVPIONUQT-RGYGYFBISA-N, Bio1_000300, Bio1_000789, Bio1_001278, Bio2_000352, Bio2_000832, HMS1362D05, HMS1792D05, HMS1990D05, HMS3403D05, Phorbol 13 Acetate 12 Myristate, 4beta,9alpha,12beta,13alpha,20-Pentahydroxytiglia-1,6-dien-3-one 12-tetradecanoate 13-acetate, KS-000019CJ, ZINC8214783, BDBM50099066, CCG-39863, MFCD00036736, NSC262244, NSC262644, AKOS024418767, CS-6053, LMPR0104330002, NSC-262644, NSC-626496, IDI1_002107, NCGC00161633-01, NCGC00161633-04, NCGC00161633-05, Phorbol 12-myristate 13-acetate diester, 4-.beta.-Phorbol 12-myristate 13-OAc, HY-18739, Phorbol 12-myristate 13-acetate (PMA), Tetradecanoic acid, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester, 12-o-tetradecanoylphorbol-13-acetate (tpa), N2060, P1585, PHORBOL-12-TETRADECANOYL-13-ACETATE, V0265, C05151, 13906-EP2270001A1, 13906-EP2277848A1, 13906-EP2305825A1, 13906-EP2316836A1, 4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha)]-, W-201494, BRD-K68552125-001-03-8, BRD-K68552125-001-04-6, I14-85837, Phorbol 12-myristate 13-acetate, synthetic, >=98.0% (TLC), PMA, for use in molecular biology applications, >=99% (TLC), Phorbol 12-myristate 13-acetate, >=99% (TLC), film or powder, 4|A,9|A,12|A,13|A,20-Pentahydroxytiglia-1,6-dien-3-one 12-tetradecanoate 13-acetate, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a- (Acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl tetradecanoate, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-acetoxy-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-1H-cyclopropa[3,4]benzo[1,2-e]azulen-9-yl tetradecanoate, (1AR,1bS,4aR,7aS,7bS,8R,9R,9aS);-9a-acetoxy-4a,7b-dihydroxy-3-(hydroxymethyl);-1,1,6,8-tetramethyl-5-oxo-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-1H-cyclopropa[3,4]benzo[1,2-e]azulen-9-yl tetradecanoate, (1S,2S,6R,10S,11R,13S,14R,15R)-13-(acetyloxy)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0^{2,6}.0^{11,13}]pentadeca-3,8-dien-14-yl tetradecanoate, 11016-13-0, 11019-85-5, 20839-11-6, 26894-58-6, 27534-73-2, 51898-14-7, 5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one, 1,1a-beta,1b-alpha,4,4a,7a-beta,7b,8,9,9a-decahydro-4a-alpha,7b-beta,9-alpha,9a-beta-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-beta-tetramethyl-, 9a-acetate 9-m, Myristic acid, 9-ester with 1,1aalpha,1bbeta,4,4a,7aalpha,7b,8,9,9a-decahydro-4abeta,7balpha,9beta,9aalpha-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8alpha-tetramethyl-5H-cyclopropa[3,4]benz[1,2-e]azulen-5, tetradecanoic acid, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9, Tetradecanoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester, [1aR-(1aalpha,1bbeta,, Tetradisant-[[4-(1, 1-oxideomega.-[2-(dodecylthio)ethoxy]-,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-, mixt. with denatured calf thymus DNAA, (2S-cis)-, compd. with sulfinylbis[methane] (2:1)2S-cis)-1:9)